|
|
|
Advertisement |
INTAC® is an abuse deterrent technology that can be tailored to a variety of immediate and extended release profiles. Learn more on the INTAC® website about how you can protect your pill.
|
Advertisement |
2017 Real-World Evidence Benchmark Survey Deloitte's 2017 Real-World Evidence Benchmark Survey shows that life sciences companies are making some progress in using RWE but still have opportunities to expand applications across the value chain, consider new channels to access RWD, and improve their overall capabilities.
Explore this research Today! |
Advertisement |
Talking the Patients' Language – the importance of effective, patient-centered engagement Live Webinar: Tuesday, June 6 at 8:00am EDT
Register now |
|
|
ADVERTISEMENT

Industry update |
//Bioventus (Durham, NC) named David Varner Vice President of Marketing, Active Healing Therapies.//Ash Keswani joined Cogentix Medical (Minneapolis, MN) as SVP of Marketing and Business Development.//McCann Health appointed two managing directors, Robert Paglia and Randy Goodman, to its New York team.// |
Advertisement |
Winning the RAT race: A new Center of Excellence to drive development of regenerative medicines Live Webinar: Tuesday, May 2 at 11:00am EDT
Register now |
|
|
|
|
|